S. No

Item No

Name of the applicant

Gist of the proposal

Sector

FDI (Rs.  crore)

1

3

M/s Aurobindo Pharma Limited

M/s Aurobindo Pharma Limited has sought an approval for the following categories:
 (i) Grant of ESOPs to non-resident employee of Aurobindo Pharma Limited, after issue of Press Note 3 of 08.11.2011, which remained unexercised as on 11.06.2015, and against which no shares were issued upto as on 11th June 2015,(which could be vested and exercised later on and shares issued against them at that stage), totalling to 2,42,600 ESOPs and exercise amount aggregating to INR 1,11,11,080/-.
(ii) Grant of ESOPs to non-resident employee of Aurobindo Pharma Limited, after issue of Press Note 3 of 8 November 2011, which were exercised and shares issued against them after 8 November 2011 but before 11 June 2015, totalling to 1,18,700 ESOPs and the exercise amount aggregating to INR 1,08,72,920/-

Pharma

2.19

2

5

Sterling Commerce Solutions India Private Limited

Approval has been sought by Sterling Commerce for acting as an Investing company for
a) Curan software international Private Limited, Emptoris Technologies India Private Limited, Kenexa technologies Private Limited and Rational Software Corporation (India) Private Limited, which are currently owned by Overseas companies of IBM and currently dormant companies.
b) From time to time act as an investing company for companies undertaking software development, technologies services or those which have become dormant pursuant to transfer of their business to IBM India.

Investing 

Nil

S. No.

Item No

Name of the applicant

Gist of the proposal

Sector

1

7

Mylan Laboratories Limited

a. Post facto approval for receipt of USD 34,05,869 from Mylan Luxembourg 2 Sarl on 04.12.2013 which was brought in over and above the approved FDI of USD 96 crores in 2013
b. Clarification that Clause 2(i) of FIPB approval dated May 8, 2015 and Clause 2(I) of FIPB approval dated November 12, 2015 do not apply to the NLEM drugs manufactured by MLL.

Pharma

2

8

Vodafone India Limited

Approval for the proposed acquisition of the entire share capital (100%) of M/s You Broadband India Limited.

Telecom

3

12

M/s Reckitt Benckiser (India) Limited.

M/s Reckitt Benckiser (India) Limited, a WOS of the Reckitt group, proposes to acquire 25.028% paid up share capital of M/s Reckitt Benckiser Healthcare India Limited from its current foreign investor viz. M/s Reckitt Benckiser (Singapore) Pte. Ltd., Singapore

Pharma

S. No.

Item No

Name of the applicant

Gist of the proposal

Sector

1

2

Rizobactor Argentina, S.A

Approval for making investment in India through creating its wholly owned subsidiary for the purpose of dealing in liquid inoculants and bio-fertilizers and adjuvants.

Pharma

2

4

M/s Indian Energy Exchange Limited

Approval has been sought by M/s Indian Energy Exchange Limited to remove compounding condition which was imposed vide letter dated 29.05.2015.

Power exchange

3

6

M/s Veritas (India) Limited

M/s Veritas (India) Limited has sought post facto approval for the issuance of 4,00,000 warrants convertible into equity shares for an aggregate consideration of INR 50 crore.

Trade and distribution

4

9

M/s BMJ Group India Private Limited

Approval has been sought  to expand the scope of its business activities by engaging in the business of publication of certain scientific/specialty healthcare journals/periodical in line with the original edition of foreign publication being published by its holding company i.e. M/s BMJ Publishing Group Limited, United Kingdom.

Publishing

5

10

M/s CevaSanteAnimale

Approval for investment by in M/s Polchem Hygiene Laboratories Private Limited by way of purchase of shares of the investee company from existing resident shareholders in 2 tranches

Pharma

6

13

M/s Sharekhan limited

Acquisition of up to 100% of the share capital of Sharekhan Limited other than the shares held in Sharekhan Limited by Human Value Developers Private Limited by BNP Paribas SA France and/or one or more of BNP’s French subsidiaries, andacquisition of 100% capital of Human Value Developers Private Limited by BNP and/ or one or more of BNP’s French subsidiaries.

NBFC

7

14

M/s Exzatech Solutions Ltd

Approval has been sought to incorporate a wholly owned subsidiary in India whose main operations would be in the field of IT Sector. As the applicant company is situated in Bangladesh and is going to incorporate a wholly owned subsidiary company in India, it comes under approval route

IT/ITES